Esperion Therapeutics (ESPR) Debt Ratio (2012 - 2026)

Esperion Therapeutics has reported Debt Ratio for 9 years, with the latest figure at 0.33 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 24.38% year-over-year to 0.33; the trailing twelve-month figure through Mar 2026 stood at 0.33 (down 24.38% YoY), and the FY2025 full-year result was 0.33, down 20.31% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.33, up from 0.33 in the prior quarter.
• The five-year high for Debt Ratio was 0.44 in Q1 2025, with the low at 0.33 in Q4 2025.
• Historically, Debt Ratio has averaged 0.39 across 3 years, with a median of 0.41 in 2024.
• Annual changes were most pronounced in 2025 — Debt Ratio slipped 20.31% — and 2026, when it decreased 24.38%.
• Esperion Therapeutics' Debt Ratio stood at 0.41 in 2024, then slipped by 20.31% to 0.33 in 2025, then rose by 1.03% to 0.33 in 2026.
• The last three Debt Ratio figures came in at 0.33 (Q1 2026), 0.33 (Q4 2025), and 0.42 (Q3 2025), per Business Quant data.